Macrophage Polarization Contributes to Glioblastoma Eradication by Combination Immunovirotherapy and Immune Checkpoint Blockade

Fares Nigim, Jill Cavanaugh, Anoop P. Patel, William T. Curry, Shin-ichi Esaki, Ekkehard M. Kasper, Andrew S. Chi, David N. Louis, Robert L. Martuza, Samuel D. Rabkin, Hiroaki Wakimoto, Targeting Hypoxia-Inducible Factor 1α in a New Orthotopic Model of Glioblastoma Recapitulating the Hypoxic Tumor Microenvironment. Journal of Neuropathology and Experimental Neurology. ,vol. 74, pp. 710- 722 ,(2015) , 10.1097/NEN.0000000000000210

Juan J. Rojas, Padma Sampath, Weizhou Hou, Steve H. Thorne, Defining Effective Combinations of Immune Checkpoint Blockade and Oncolytic Virotherapy Clinical Cancer Research. ,vol. 21, pp. 5543- 5551 ,(2015) , 10.1158/1078-0432.CCR-14-2009

Powell Perng, Michael Lim, Immunosuppressive Mechanisms of Malignant Gliomas: Parallels at Non-CNS Sites Frontiers in Oncology. ,vol. 5, pp. 153- 153 ,(2015) , 10.3389/FONC.2015.00153

Danielle M Lussier, John L Johnson, Pooja Hingorani, Joseph N Blattman, Combination immunotherapy with α-CTLA-4 and α-PD-L1 antibody blockade prevents immune escape and leads to complete control of metastatic osteosarcoma. Journal for ImmunoTherapy of Cancer. ,vol. 3, pp. 21- 21 ,(2015) , 10.1186/S40425-015-0067-Z

Matthias Preusser, Michael Lim, David A. Hafler, David A. Reardon, John H. Sampson, Prospects of immune checkpoint modulators in the treatment of glioblastoma. Nature Reviews Neurology. ,vol. 11, pp. 504- 514 ,(2015) , 10.1038/NRNEUROL.2015.139

Norman Woller, Engin Gürlevik, Bettina Fleischmann-Mundt, Anja Schumacher, Sarah Knocke, Arnold M Kloos, Michael Saborowski, Robert Geffers, Michael P Manns, Thomas C Wirth, Stefan Kubicka, Florian Kühnel, Viral Infection of Tumors Overcomes Resistance to PD-1-immunotherapy by Broadening Neoantigenome-directed T-cell Responses. Molecular Therapy. ,vol. 23, pp. 1630- 1640 ,(2015) , 10.1038/MT.2015.115

Sergio A. Quezada, Karl S. Peggs, Tyler R. Simpson, James P. Allison, Shifting the equilibrium in cancer immunoediting: from tumor tolerance to eradication Immunological Reviews. ,vol. 241, pp. 104- 118 ,(2011) , 10.1111/J.1600-065X.2011.01007.X

Nicholas Butowski, Howard Colman, John F. De Groot, Antonio M. Omuro, Lakshmi Nayak, Patrick Y. Wen, Timothy F. Cloughesy, Adhirai Marimuthu, Sam Haidar, Arie Perry, Jason Huse, Joanna Phillips, Brian L. West, Keith B. Nolop, Henry H. Hsu, Keith L. Ligon, Annette M. Molinaro, Michael Prados, Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study Neuro-oncology. ,vol. 18, pp. 557- 564 ,(2016) , 10.1093/NEUONC/NOV245

Justin D. Lathia, Stephen C. Mack, Erin E. Mulkearns-Hubert, Claudia L.L. Valentim, Jeremy N. Rich, Cancer stem cells in glioblastoma Genes & Development. ,vol. 29, pp. 1203- 1217 ,(2015) , 10.1101/GAD.261982.115

Stefano Ugel, Francesco De Sanctis, Susanna Mandruzzato, Vincenzo Bronte, Tumor-induced myeloid deviation: when myeloid-derived suppressor cells meet tumor-associated macrophages Journal of Clinical Investigation. ,vol. 125, pp. 3365- 3376 ,(2015) , 10.1172/JCI80006